ProMIS Neurosciences Inc. (PMN) Stock

About ProMIS Neurosciences Inc.

ProMIS Neurosciences Inc. is led by CEO Neil K. Warma, employs 7 people, headquartered in CA, publicly traded since 2007.

ProMIS Neurosciences Inc. (PMN) stock trades at $8.34 with a market capitalization of $74.79M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.55, reflecting a net loss over the last twelve months, price-to-book of 1.73, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $6.27 and $27.40, and currently trades 69.6% below its 52-week high.

On profitability, ProMIS Neurosciences Inc. generates a return on equity (ROE) of -143.09% (negative, reflecting a net loss), return on capital employed of -87.79%.

ProMIS Neurosciences Inc. by the numbers, 2016–2025

Between 2016 and 2025 ProMIS Neurosciences Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-40.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-43.0M.

Borrowings stand at $0, cash from operations was $-28.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged 181299.5% over five years, and was 4000.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

ProMIS Neurosciences Inc. (PMN) — frequently asked questions